United Bank Abbott Laboratories Transaction History

United Bank

$857 Million
Q3 2024

A detailed history of United Bank transactions in Abbott Laboratories stock. As of the latest transaction made, United Bank holds 137,860 shares of ABT stock, worth $15.7 Million. This represents 1.83% of its overall portfolio holdings.

Number of Shares

137,860

Previous 136,873 0.72%

Holding current value

$15.7 Million

Previous $14.2 Million 10.51%

% of portfolio

1.83%

Previous 1.77%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$100.07 - $118.13 $98,769 - $116,594	987 Added 0.72%	137,860 $15.7 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $699,166 - $780,446	-6,941 Reduced 4.83%	136,873 $14.2 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $1.08 Million - $1.2 Million	-9,900 Reduced 6.44%	143,814 $16.3 Million
Q4 2023 Feb 07, 2024	SELL	$90.19 - $110.4 $361,481 - $442,483	-4,008 Reduced 2.54%	153,714 $16.9 Million
Q3 2023 Nov 08, 2023	SELL	$95.53 - $114.62 $264,904 - $317,841	-2,773 Reduced 1.73%	157,722 $15.3 Million
Q2 2023 Aug 03, 2023	SELL	$100.78 - $112.29 $338,016 - $376,620	-3,354 Reduced 2.05%	160,495 $17.5 Million
Q1 2023 May 01, 2023	BUY	$96.86 - $114.01 $217,838 - $256,408	2,249 Added 1.39%	163,849 $16.6 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $278,050 - $326,196	2,925 Added 1.84%	161,600 $17.7 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $80,601 - $93,320	833 Added 0.53%	158,675 $15.4 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $140,142 - $169,387	1,373 Added 0.88%	157,842 $17.2 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $507,274 - $618,588	-4,449 Reduced 2.76%	156,469 $18.5 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $264,563 - $323,943	-2,290 Reduced 1.4%	160,918 $22.6 Million
Q3 2021 Oct 21, 2021	BUY	$116.66 - $129.06 $143,491 - $158,743	1,230 Added 0.76%	163,208 $19.3 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $363,706 - $428,134	-3,438 Reduced 2.08%	161,978 $18.8 Million
Q1 2021 Apr 23, 2021	SELL	$108.84 - $128.23 $480,963 - $566,648	-4,419 Reduced 2.6%	165,416 $19.8 Million
Q4 2020 Feb 18, 2021	SELL	$105.0 - $114.42 $196,665 - $214,308	-1,873 Reduced 1.09%	169,835 $18.6 Million
Q3 2020 Dec 11, 2020	SELL	$91.64 - $111.29 $83,300 - $101,162	-909 Reduced 0.53%	171,708 $18.7 Million
Q2 2020 Sep 18, 2020	BUY	$76.57 - $98.0 $520,982 - $666,792	6,804 Added 4.1%	172,617 $15.8 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $42,340 - $61,913	674 Added 0.41%	165,813 $13.1 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $339,241 - $377,655	-4,321 Reduced 2.55%	165,139 $14.3 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $1.32 Million - $1.43 Million	-16,124 Reduced 8.69%	169,460 $14.2 Million
Q2 2019 Aug 15, 2019	BUY	$72.88 - $85.0 $627,059 - $731,340	8,604 Added 4.86%	185,584 $15.6 Million
Q1 2019 May 16, 2019	SELL	$66.22 - $80.06 $1.42 Million - $1.72 Million	-21,432 Reduced 10.8%	176,980 $14.1 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $162,588 - $184,189	2,480 Added 1.27%	198,412 $14.4 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $31,073 - $37,486	511 Added 0.26%	195,932 $14.4 Million
Q2 2018 Aug 20, 2018	SELL	$57.57 - $63.54 $98,156 - $108,335	-1,705 Reduced 0.86%	195,421 $11.9 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $594,773 - $672,463	-10,570 Reduced 5.09%	197,126 $11.8 Million
Q4 2017 Feb 15, 2018	BUY	$53.68 - $57.47 $6.23 Million - $6.67 Million	115,998 Added 126.5%	207,696 $11.9 Million
Q3 2017 Oct 27, 2017	SELL	$48.06 - $53.64 $195,652 - $218,368	-4,071 Reduced 4.25%	91,698 $4.89 Million
Q2 2017 Aug 23, 2017	BUY	N/A	95,769	95,769 $4.66 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Bank, based on Form 13F filings with the SEC.

News

Stay updated on United Bank with notifications on news.

Account